These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6532124)

  • 41. Role of prostaglandins in gastroprotection and gastric adaptation.
    Brzozowski T; Konturek PC; Konturek SJ; Brzozowska I; Pawlik T
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 5():33-55. PubMed ID: 16247188
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of neuropeptide Y and [Leu31,Pro34] neuropeptide Y on experimental gastric lesion formation and gastric secretion in the rat.
    Penner SB; Smyth DD; Glavin GB
    J Pharmacol Exp Ther; 1993 Jul; 266(1):339-43. PubMed ID: 8101219
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of sepsis-induced gastric lesions in dogs by cimetidine via inhibition of gastric secretion and by prostaglandin via cytoprotection.
    Odonkor P; Mowat C; Himal HS
    Gastroenterology; 1981 Feb; 80(2):375-9. PubMed ID: 7450426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostaglandin and protection of the gastroduodenal mucosa.
    Johansson C; Bergström S
    Scand J Gastroenterol Suppl; 1982; 77():21-46. PubMed ID: 6750829
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Local effects of 16, 16-dimethyl prostaglandin E2 on gastric blood flow and acid secretion.
    Cheung LY; Lowry SF
    Surgery; 1981 Aug; 90(2):291-8. PubMed ID: 7256541
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevention of the acetylsalicylic acid-induced changes of the gastric potential difference by the new synthetic prostaglandin E1 analogue rioprostil.
    Demol P; Schmitz HD; Weihrauch TR; Kuhlmann J
    Arzneimittelforschung; 1986 Sep; 36(9):1406-8. PubMed ID: 3098255
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostaglandins and chemotherapy-induced ulcers in dogs.
    Bright-Asare P; Giannikopoulos I; Whiten JT
    Dig Dis Sci; 1985 Nov; 30(11 Suppl):201S-203S. PubMed ID: 2932323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Influence of long-term 16,16-dimethyl prostaglandin E2 treatment on the rat gastrointestinal mucosa.
    Reinhart WH; Müller O; Halter F
    Gastroenterology; 1983 Nov; 85(5):1003-10. PubMed ID: 6618097
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional cytoprotection by certain antacids.
    Szelényi I
    Acta Physiol Hung; 1984; 64(3-4):259-68. PubMed ID: 6598001
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bile salt-induced, acute gastric mucosal damage in man: time course and effect of misoprostol, a PGE1-analogue.
    Fimmel CJ; Müller-Lissner SA; Blum AL
    Scand J Gastroenterol Suppl; 1984; 92():184-8. PubMed ID: 6429843
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of adrenalectomy on prostaglandin protection of the rat gastric mucosa.
    Reichstein BJ; Ricer M; Cohen MM
    Can J Surg; 1984 Mar; 27(2):141-3. PubMed ID: 6704816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of prostaglandin E2 and ranitidine in prevention of gastric bleeding by aspirin in man.
    Konturek SJ; Kwiecień N; Obtułowicz W; Polański M; Kopp B; Oleksy J
    Gut; 1983 Feb; 24(2):89-93. PubMed ID: 6133815
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Effects of enprostil on changes in the gastric transepithelial potential differential induced by aspirin].
    Florent C; Desaint B; Joubert M; Maurel M; Bernier JJ
    Gastroenterol Clin Biol; 1987 Dec; 11(12):886-90. PubMed ID: 3130280
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of PGF2 alpha administered in cytoprotective and antisecretory doses on the ethanol- and HCl-induced gastric mucosal damage and gastric mucosal superoxide dismutase activity in rats.
    Czeglédi B; Zsoldos T; Mózsik G
    Acta Physiol Hung; 1984; 64(3-4):331-7. PubMed ID: 6598002
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of central prostaglandin E2 in the regulation of gastric acid secretion in the rat.
    Saperas E; Kauffman G; Taché Y
    Eur J Pharmacol; 1991 Dec; 209(1-2):1-7. PubMed ID: 1814754
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa.
    Lichtenberger LM; Richards JE; Hills BA
    Gastroenterology; 1985 Jan; 88(1 Pt 2):308-14. PubMed ID: 3964778
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effect of 16,16-dimethyl-PG E2 on the 24 hours intragastric acidity in man].
    Dammann HG; Müller P; Simon B
    Z Gastroenterol; 1982 Oct; 20(10):613-6. PubMed ID: 7157904
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drugs, gastritis, and peptic ulcer.
    Ivey KJ
    J Clin Gastroenterol; 1981; 3(Suppl 2):29-34. PubMed ID: 7320467
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prophylactic effect of lafutidine against the adverse reaction induced in rat stomach by repeated administration of 5-fluorouracil.
    Kotani T; Nakagiri A; Murashima Y; Takeuchi K
    Inflammopharmacology; 2007 Oct; 15(5):203-8. PubMed ID: 17943252
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.
    Takeuchi K; Ukawa H; Konaka A; Kitamura M; Sugawa Y
    J Pharmacol Exp Ther; 1998 Jul; 286(1):115-21. PubMed ID: 9655849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.